About
Monoclonal Antibody & Small Molecule Targeting Infectious Diseases
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyBiotech
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
562
By Phase
PHASE3: 3PHASE1/PHASE2: 2PHASE2: 1PHASE1: 1
By Status
COMPLETED: 4TERMINATED: 2UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05331885Lead Sponsor
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
PHASE3Terminated
24 participants
Started: Sep 2, 2022 · Completed: Jul 8, 2024
NCT03926156Collaborator
RIvoraxaban in Mitral Stenosis
PHASE3Terminated
40 participants
Started: May 22, 2019 · Completed: Aug 14, 2021
NCT03816956Lead Sponsor
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
PHASE3Completed
174 participants
Started: May 3, 2019 · Completed: Oct 28, 2022
NCT03669614Lead Sponsor
SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects
PHASE1/PHASE2Unknown
102 participants
Started: Dec 7, 2018 · Completed: Jul 31, 2023
NCT03027609Lead Sponsor
Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia
PHASE2Completed
158 participants
Started: Mar 29, 2017 · Completed: Apr 25, 2019
Locations (1)
Headquarters
Los Gatos, CA, United States
Map
Loading map...